VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Thursday, January 1, 2026

Stock Comparison

Amgen Inc. vs Parker-Hannifin Corporation

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Amgen Inc.

AMGN · Nasdaq Stock Market

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-22
Moat score
70/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Amgen Inc.'s moat claims, evidence, and risks.

View AMGN analysis

Parker-Hannifin Corporation

PH · New York Stock Exchange

Market cap (USD)$111.4B
SectorIndustrials
CountryUS
Data as of2025-12-31
Moat score
71/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Parker-Hannifin Corporation's moat claims, evidence, and risks.

View PH analysis

Comparison highlights

  • Moat score gap: Parker-Hannifin Corporation leads (71 / 100 vs 70 / 100 for Amgen Inc.).
  • Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Parker-Hannifin Corporation has 2 segments (68.8% in Diversified Industrial).
  • Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Parker-Hannifin Corporation has 5 across 2.

Primary market context

Amgen Inc.

Core Innovative Medicines

Market

Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)

Geography

Global

Customer

Payers, providers, and pharmacies

Role

Drug developer/manufacturer

Revenue share

80.1%

Parker-Hannifin Corporation

Diversified Industrial

Market

Motion and control components & systems (industrial and mobile applications)

Geography

Global

Customer

OEMs and industrial distributors/aftermarket channels

Role

Component and system designer/manufacturer with aftermarket support

Revenue share

68.8%

Side-by-side metrics

Amgen Inc.
Parker-Hannifin Corporation
Ticker / Exchange
AMGN - Nasdaq Stock Market
PH - New York Stock Exchange
Market cap (USD)
n/a
$111.4B
Sector
Healthcare
Industrials
HQ country
US
US
Primary segment
Core Innovative Medicines
Diversified Industrial
Market structure
Competitive
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
70 / 100
71 / 100
Moat domains
Legal, Supply, Demand
Supply, Demand
Last update
2025-12-22
2025-12-31

Moat coverage

Shared moat types

No overlap yet.

Amgen Inc. strengths

IP Choke PointRegulated Standards PipeCapex Knowhow ScaleBrand TrustLearning Curve Yield

Parker-Hannifin Corporation strengths

Distribution ControlDesign In QualificationScope EconomiesOperational ExcellenceInstalled Base Consumables

Segment mix

Amgen Inc. segments

Full profile >

Core Innovative Medicines

Competitive

80.1%

Rare Disease Portfolio (Horizon + others)

Quasi-Monopoly

13.3%

Biosimilars

Oligopoly

6.6%

Parker-Hannifin Corporation segments

Full profile >

Diversified Industrial

Competitive

68.8%

Aerospace Systems

Oligopoly

31.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.